Firstar Healthcare Oy – Trademark Portfolio

Entity Type: 99

Firstar Healthcare Oy holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ONE-AID and AQUA-ZERO.

Yliopistonkatu 31, 3rd floor

FI-20100 Turku

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ONE-AID
ONE-AID
Registered 2024
AQUA-ZERO
AQUA-ZERO
Registered 2024

Trademark Classifications

Firstar Healthcare Oy's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Firstar Healthcare Oy have?

Firstar Healthcare Oy has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Firstar Healthcare Oy file in?

Firstar Healthcare Oy files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Firstar Healthcare Oy's most well-known trademarks?

Firstar Healthcare Oy's registered trademark portfolio includes well-known marks such as ONE-AID and AQUA-ZERO. These are among 2 currently registered trademarks in the portfolio.

What is Firstar Healthcare Oy's trademark registration success rate?

Firstar Healthcare Oy has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.